Previous research suggesting loss of smell function may serve as an early marker of Alzheimer's disease has now been supported by a finding that in genetically engineered mice, loss of smell function is associated with amyloid-beta accumulation in the brain, and that amyloid pathology occurs first in the olfactory region. It was striking how sensitive olfactory performance was to even the smallest amount of amyloid presence in the brain as early as three months of age (equivalent to a young adult).
Loss of smell may predict early onset of Alzheimer's
Reference
Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010). Olfactory Dysfunction Correlates with Amyloid-{beta} Burden in an Alzheimer’s Disease Mouse Model. J. Neurosci., 30(2), 505-514. Retrieved from http://www.jneurosci.org/cgi/content/abstract/30/2/505
Related News
Friends, family detect early Alzheimer's signs better than traditional tests
Confirming earlier research, a study involving 257 older adults (average age 75) has found that a two-minute questionnaire filled out by a close friend or family member is more accurate that standard cognitive tests in detecting early signs of Alzheimer’s.
The AD8 asks questions about changes in everyday activities:
Losing muscle mass early sign of Alzheimer’s
Previous research has found that unexplained weight loss is an early sign of Alzheimer's. Now a study involving 140 older adults (60+), of whom half had early-stage Alzheimer's disease, has revealed that it is not the overall weight or fat levels that are important, but the loss of lean mass (weight of an individual's bones, muscles and organs without body fat). This directly correlated with reductions in the volume of the whole brain and of white matter only, along with declines in cognitive performance.
Damaged protein identified as early biomarker for Alzheimer's
A study involving 57 cognitively healthy older adults has found that those who showed decreased memory performance two years later (20 of the 57) had higher baseline levels of phosphorylated tau231 in the cerebrospinal fluid, and more atrophy in the medial temporal lobe. Higher levels of damaged tau protein were associated with reductions in medial temporal lobe gray matter. The finding may be useful in early diagnosis of Alzheimer’s disease.
Mental fluctuations may signal Alzheimer's disease
A study involving 511 older adults (average age 78) has found that 11.6% of those with very mild or mild Alzheimer’s (43% of the participants) had mental lapses, compared to only 2 of the 295 without Alzheimer’s. Those with mental lapses also tended to have more severe Alzheimer’s. Although mental lapses are characteristic of dementia with Lewy bodies, this is the first study to look at them in connection with Alzheimer’s. Having mental lapses was defined as having three or four of the following symptoms:
Specific hippocampal atrophy early sign of MCI & Alzheimer's
A three-year study involving 169 people with mild cognitive impairment has found that those who later developed Alzheimer's disease showed 10-30% greater atrophy in two specific locations within the hippocampus, the cornu ammonis (CA1) and the subiculum.
Variations in eye structure and function seen early in Alzheimer's
Submitted by Fiona McPherson
on
More evidence for early changes in the eye in Alzheimer’s disease comes from a study involving both rats and postmortem human retinas. Changes were found in the retinal pigment epithelial layer (which harbors the supportive cells located in the back of the eye) and in the thickness of the choroidal layer that has blood vessels providing nutrients to the retina.
The finding is consistent with growing evidence that glaucoma is a neurodegenerative disorder similar to Alzheimer’s.
Tau-amyloid ratio predicts MCI
Submitted by Fiona McPherson
on
Initial findings from an analysis of cerebrospinal fluid taken between 1995 and 2005 from 265 middle-aged healthy volunteers, of whom 75% had a close family member with Alzheimer’s disease, has found that the ratios of phosphorylated tau and amyloid-beta could predict mild cognitive impairment more than five years before symptom onset — the more tau and less amyloid-beta, the more likely MCI will develop. The rate of change in the ratio over time was also predictive — the more rapidly the ratio of tau to amyloid-beta went up, the more likely the eventual development of MCI.
Brainwaves indicate the presence and severity of Alzheimer's
Submitted by Fiona McPherson
on
Comparison of the EEGs of 27 healthy older adults, 27 individuals with mild Alzheimer's and 22 individuals with moderate cases of Alzheimer’s, has found statistically significant differences across the three groups, using an algorithm that dissects brain waves of varying frequencies.
Gene variation associated with brain atrophy in MCI
Submitted by Fiona McPherson
on
Analysis of data from 237 patients with mild cognitive impairment (mean age 79.9) has found that, compared to those carrying the ‘normal’ ApoE3 gene (the most common variant of the ApoE gene), the ApoE4 carriers showed markedly greater rates of shrinkage in 13 of 15 brain regions thought to be key components of the brain networks disrupted in Alzheimer’s.
http://www.eurekalert.org/pub_releases/2014-01/rson-gva010714.php
Dementia sufferers become unaware of memory problems years before diagnosis
A ten-year study involving 2,092 older adults (average age 76) has found that people tended to lose awareness of memory problems two to three years before the onset of dementia.
Being unaware of your own memory problems is common in dementia, but previous research has focused on those already diagnosed with dementia. In this study, participants had no cognitive impairment at the beginning of the study.